Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2018: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2017: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
We recently identified coiled-coil-helix coiled-coil-helix domain containing 2 (CHCHD2) mutations are novel causes for autosomal dominant Parkinson’s disease (PD). Although CHCHD2 is localized to mitochondria and involved in mitochondrial complex IV, its function remains largely unknown. To elucidate the role of CHCHD2 in mitochondria, we generated CHCHD2 knockout SH-SY5Y neuroblastoma cells (CHCHD2-KO) and induced pluripotent stem cells (iPSc) derived from PD patient with CHCHD2 T61I mutation. CHCHD2-KO as well as iPS showed a profound mitochondrial dysfunction, suggesting that CHCHD2 plays a crucial role in maintaining normal mitochondrial function. These findings indicate that CHCHD2 cellular models are a useful model for understanding CHCHD2 function and pathophysiology of CHCHD2 mutations and PD.
|